OQS
CLBT icon

Occudo Quantitative Strategies’s Cellebrite CLBT Stock Holding History

Occudo Quantitative Strategies’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-40,824
Closed -$687K – 710
2024
Q3 		$687K Buy
40,824
+14,139
+53% +$210K 0.13% 204
2024
Q2 		$319K Sell
26,685
-36,493
-58% -$408K 0.06% 440
2024
Q1 		$700K Sell
63,178
-88,866
-58% -$907K 0.12% 236
2023
Q4 		$1.32M Buy
152,044
+84,733
+126% +$659K 0.18% 158
2023
Q3 		$515K Buy
67,311
+37,579
+126% +$282K 0.07% 480
2023
Q2 		$214K Buy
+29,732
New +$173K 0.02% 832
2022
Q2 		– Sell
-28,939
Closed -$185K – 1164
2022
Q1 		$185K Sell
28,939
-2,118
-7% -$14K 0.02% 955
2021
Q4 		$249K Buy
+31,057
New +$293K 0.02% 829

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AE
Axon Enterprise Scottsdale, Arizona $19.1M AUM 8.75% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
CC
Crosslink Capital Menlo Park, California $1.35B AUM 35.86% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return

Occudo Quantitative Strategies's CLBT Position: Q4 2024 in Review

Occudo Quantitative Strategies sold out of Cellebrite (CLBT) in Q4 2024, closing a stake of 40,824 shares — an estimated $687K sold.

Occudo Quantitative Strategies first reported a position in CLBT in Q4 2021 and held it in 8 quarters. The position peaked at $1.32M in Q4 2023. 191 funds tracked by Wall St. Rank hold CLBT as of Q4 2024.

  • Occudo Quantitative Strategies reported no remaining Cellebrite position as of Q4 2024 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 40,824 Cellebrite shares in Q4 2024, an estimated $687K.
  • Occudo Quantitative Strategies first reported a position in Cellebrite in Q4 2021 and held it in 8 quarters.
  • Occudo Quantitative Strategies's Cellebrite position peaked at $1.32M in Q4 2023.
  • 191 funds tracked by Wall St. Rank held Cellebrite as of Q4 2024.

Based on Occudo Quantitative Strategies's 13F filing for Q4 2024, filed 14 Feb 2025.